DM
Dolphin Medical Services
Healthcare Services
526504 BSE
₹7.11
Close ·
- P/E
- 177.75
Close 2 Nov 2026 ₹7.11 +5.04 +243% 1Y
Start ₹2.07
Key Fundamentals
MicrocapHealthcare ServicesHealthcarePrice-based figures at the close · EPS basis: Standalone · TTM
- ROCE
- 0.64%
- Debt to Equity
- 0.09
- EPS (TTM)
- ₹0.04
- Book Value
- ₹6.68
- Market Cap
- —
- P/E (TTM)
- 177.75
- P/B
- 1.06
- ROE
- 0.60%
- Dividend Yield
- 0.00%
- EBITDA
- ₹30.00 L
- 52W High
- ₹9.57
- 52W Low
- ₹1.99
Key Insights
Strengths
2- Company is almost debt free.
- Stock is trading at 0.99 times its book value
Weaknesses
3- The company has delivered a poor sales growth of 9.80% over past five years.
- Promoter holding is low: 26.4%
- Company has a low return on equity of -0.23% over last 3 years.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bullish | 3 | 6 | 10 |
| Oscillators | Bearish | 2 | 6 | 1 |
| Moving Averages | Strong Bullish | 1 | 0 | 9 |
Oscillators
Bearish
Bearish
2
Neutral
6
Bullish
1
Overall
Strong Bullish
Bearish
3
Neutral
6
Bullish
10
Moving Averages
Strong Bullish
Bearish
1
Neutral
0
Bullish
9
Key readings
- RSI (14)
- 57.35
- Neutral
- MACD (12,26,9)
- 0.17
- Bearish
- SMA (50)
- 5.62
- Bullish
- SMA (200)
- 2.97
- Bullish
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +2.78% |
|---|---|
| 5Y | +9.80% |
| 3Y | +7.13% |
| 1Y | −3.85% |
| TTM | −1.25% |
Net profit
| 10Y | Turned to profit |
|---|---|
| 5Y | Turned to profit |
| 3Y | Turned to profit |
| 1Y | Turned to profit |
| TTM | Turned to profit |
Operating cash flow
| 10Y | Turned positive |
|---|---|
| 5Y | −12.31% |
| 3Y | Turned positive |
| 1Y | Turned positive |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −15.58 pp |
|---|---|
| 5Y | Tiny sales |
| 3Y | +29.11 pp |
| 1Y | +16.00 pp |
| TTM | +11.41 pp |
Revenue by year
| Mar 2017 | ₹0.35 Cr |
|---|---|
| Mar 2018 | ₹0.15 Cr |
| Mar 2019 | ₹0.06 Cr |
| Mar 2020 | ₹0.18 Cr |
| Mar 2021 | ₹0.47 Cr |
| Mar 2022 | ₹0.52 Cr |
| Mar 2023 | ₹0.61 Cr |
| Mar 2024 | ₹0.68 Cr |
| Mar 2025 | ₹0.78 Cr |
| Mar 2026 | ₹0.75 Cr |
Net profit by year
| Mar 2017 | −₹0.27 Cr |
|---|---|
| Mar 2018 | −₹0.30 Cr |
| Mar 2019 | −₹1.01 Cr |
| Mar 2020 | −₹0.39 Cr |
| Mar 2021 | −₹0.31 Cr |
| Mar 2022 | −₹0.19 Cr |
| Mar 2023 | −₹0.12 Cr |
| Mar 2024 | −₹0.10 Cr |
| Mar 2025 | −₹0.03 Cr |
| Mar 2026 | ₹0.06 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.15 | 0.18 | 0.2 | 0.14 | 0.14 | 0.25 | 0.24 | 0.14 | 0.17 | 0.18 | 0.21 | 0.19 | 0.21 |
| Expenses | 0.13 | 0.17 | 0.2 | 0.27 | 0.13 | 0.23 | 0.23 | 0.19 | 0.14 | 0.16 | 0.18 | 0.17 | 0.18 |
| Operating Profit | 0.02 | 0.01 | 0 | −0.13 | 0.01 | 0.02 | 0.01 | −0.05 | 0.03 | 0.02 | 0.03 | 0.02 | 0.03 |
| OPM % | 13.33% | 5.56% | 0% | −92.86% | 7.14% | 8% | 4.17% | −35.71% | 17.65% | 11.11% | 14.29% | 10.53% | 14.29% |
| Other Income | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 | 0.03 | 0.03 | 0.02 | 0.02 |
| PBT | 0.02 | 0.01 | 0 | −0.13 | 0.01 | 0.02 | 0.01 | −0.07 | 0.03 | 0 | 0.01 | 0.01 | 0.02 |
| Tax % | 0% | 0% | — | 7.69% | 0% | 0% | 0% | 0% | 0% | — | 0% | 0% | 0% |
| Net Profit | 0.01 | 0.01 | 0 | −0.13 | 0.01 | 0.02 | 0.01 | −0.07 | 0.03 | 0.01 | 0.02 | 0.01 | 0.02 |
| EPS (₹) | 0.01 | 0.01 | 0 | −0.09 | 0.01 | 0.01 | 0.01 | −0.05 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.36 | 0.57 | 0.35 | 0.15 | 0.06 | 0.18 | 0.47 | 0.52 | 0.61 | 0.68 | 0.78 | 0.75 | 0.79 |
| Expenses | 0.39 | 0.39 | 0.33 | 0.23 | 0.2 | 0.52 | 6.24 | 0.66 | 0.69 | 0.76 | 0.78 | 0.63 | 0.69 |
| Operating Profit | −0.03 | 0.18 | 0.02 | −0.08 | −0.14 | −0.34 | −5.77 | −0.14 | −0.08 | −0.08 | 0 | 0.12 | 0.1 |
| OPM % | −8.33% | 31.58% | 5.71% | −53.33% | −233.33% | −188.89% | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | −26.92% | −13.11% | −11.76% | 0% | 16% | 12.66% |
| Other Income | 0.01 | 0.15 | 0.02 | 0.09 | −0.63 | 0.05 | 5.55 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Interest | 0.05 | 0.06 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
| Depreciation | 0.52 | 0.34 | 0.33 | 0.33 | 0.24 | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 | 0.06 | 0.09 | 0.1 |
| PBT | −0.59 | −0.07 | −0.3 | −0.33 | −1.02 | −0.36 | −0.29 | −0.17 | −0.11 | −0.1 | −0.03 | 0.06 | 0.04 |
| Tax % | −3.39% | −28.57% | −10% | −12.12% | −1.96% | 5.56% | 6.9% | 5.88% | 9.09% | 10% | 0% | 0% | — |
| Net Profit | −0.57 | −0.05 | −0.27 | −0.3 | −1.01 | −0.39 | −0.31 | −0.19 | −0.12 | −0.1 | −0.03 | 0.06 | 0.06 |
| EPS (₹) | −0.38 | −0.03 | −0.18 | −0.2 | −0.67 | −0.26 | −0.21 | −0.13 | −0.08 | −0.07 | −0.02 | 0.04 | 0.04 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 15.1 | 15.1 | 15.1 | 15.1 | 15.1 | 15.1 | 15.1 | 15.1 | 15.1 | 15.1 | 15.1 | 15.1 |
| Reserves | −2.3 | −2.34 | −2.61 | −2.91 | −3.91 | −4.3 | −4.61 | −4.8 | −4.92 | −5.03 | −5.06 | −5.02 |
| Borrowings | 8.05 | 8.16 | 8.21 | 8.21 | 6.22 | 6.37 | 0.61 | 0.68 | 0.76 | 0.8 | 0.87 | 0.87 |
| Other Liabilities | 0.74 | 0.67 | 0.65 | 0.61 | 0.58 | 0.71 | 1.23 | 1.26 | 1.23 | 1.27 | 1.17 | 1.48 |
| Total Liabilities | 21.59 | 21.59 | 21.35 | 21.01 | 17.99 | 17.88 | 12.33 | 12.24 | 12.17 | 12.14 | 12.08 | 12.43 |
| Fixed Assets | 14.5 | 10.36 | 10.03 | 9.7 | 6.79 | 6.74 | 3 | 2.94 | 2.87 | 2.83 | 2.76 | 6.91 |
| CWIP | 2.14 | 5.93 | 5.93 | 5.93 | 5.93 | 5.93 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 0.31 |
| Investments | 0.52 | 0.52 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 |
| Other Assets | 4.43 | 4.78 | 4.98 | 4.97 | 4.86 | 4.8 | 4.83 | 4.8 | 4.8 | 4.81 | 4.82 | 4.8 |
| Total Assets | 21.59 | 21.59 | 21.35 | 21.01 | 17.99 | 17.88 | 12.33 | 12.24 | 12.17 | 12.14 | 12.08 | 12.43 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 0.05 | −0.12 | −0.07 | 0 | 0.02 | −0.13 | 0.27 | −0.1 | −0.07 | −0.05 | −0.06 | 0.14 |
| Investing | 0 | 0.01 | 0.03 | 0 | 1.97 | −0.01 | 0 | 0 | 0 | 0 | 0 | −0.45 |
| Financing | −0.05 | 0.11 | 0.05 | 0 | −1.99 | 0.15 | −0.25 | 0.07 | 0.07 | 0.05 | 0.06 | 0.31 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.03 | −0.02 | 0 | 0 | 0 | 0 |
| Free Cash Flow | 0.05 | −0.11 | −0.07 | 0 | 1.99 | −0.14 | 0.27 | −0.1 | −0.07 | −0.05 | −0.06 | −0.31 |
| CFO/OP | −167 | −56 | −200 | 0 | −14 | 38 | −5 | 71 | 88 | 62 | — | 117 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | 36.5 | 21.47 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33.18 | 30.42 | 36.5 |
| Days Payable | 73 | 0 | — | — | — | — | — | — | — | 0 | 0 | 0 |
| Cash Conversion Cycle | −36.5 | 21.47 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33.18 | 30.42 | 36.5 |
| Working Capital Days | 1,450 | 1,172 | 2,107 | 4,891 | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | 3,630 | 986 | 898 | 772 | 687 | 646 | 516 |
| ROCE % | −2.55% | −0.05% | −0.96% | −1.56% | −1.69% | −2.02% | −1.98% | −1.45% | −0.91% | −0.83% | −0.18% | 0.64% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Dolphin Medical Services insights
58 extracted metrics across FY10–FY27.
Documents
- General announcements 31 Oct 2026
- General announcements 21 Sep 2026
Frequently Asked Questions about Dolphin Medical Services
What does Dolphin Medical Services Ltd do?
Incorporated in 1984, Dolphin Medical Services Ltd is in the business of diagnostics and other allied services.
Where is Dolphin Medical Services Ltd (DOLPHMED) listed?
Dolphin Medical Services Ltd trades under code 526504 on the BSE.
Which sector does Dolphin Medical Services Ltd belong to?
Dolphin Medical Services Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the PE ratio of Dolphin Medical Services Ltd?
Dolphin Medical Services Ltd trades at a PE ratio of 177.75 as of 2 Nov 2026, on earnings per share of ₹0.04, against a book value of ₹6.68 per share.
What is the 52-week high and low of Dolphin Medical Services Ltd?
Over the last 52 weeks Dolphin Medical Services Ltd has traded between ₹1.99 and ₹9.57 as of 2 Nov 2026.
What is the Return on Equity (ROE) of Dolphin Medical Services Ltd?
Dolphin Medical Services Ltd reported a return on equity of 0.60%. Its debt-to-equity ratio is 0.09.
Company Information
Incorporated in 1984, Dolphin Medical Services Ltd is in the business of diagnostics and other allied services.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/526504.md for Dolphin Medical Services Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.